Bayesian Capital Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,256
Closed -$587K 316
2025
Q3
$587K Buy
+2,256
New +$593K 0.12% 251
2023
Q4
Sell
-9,272
Closed -$4.51M 877
2023
Q3
$4.51M Buy
+9,272
New +$4.36M 0.52% 44
2023
Q1
Sell
-3,600
Closed -$1.84M 929
2022
Q4
$1.84M Sell
3,600
-2,000
-36% -$1.05M 0.27% 75
2022
Q3
$2.72M Buy
+5,600
New +$2.72M 0.55% 32
2021
Q4
Sell
-764
Closed -$297K 444
2021
Q3
$297K Buy
+764
New +$324K 0.09% 269
2021
Q1
Sell
-2,430
Closed -$997K 606
2020
Q4
$997K Sell
2,430
-403
-14% -$168K 0.26% 104
2020
Q3
$1.17M Buy
+2,833
New +$1.14M 0.29% 87
2020
Q2
Sell
-2,844
Closed -$893K 626
2020
Q1
$893K Sell
2,844
-3,100
-52% -$1.05M 0.19% 152
2019
Q4
$2.18M Buy
5,944
+4,284
+258% +$1.36M 0.37% 54
2019
Q3
$424K Buy
+1,660
New +$465K 0.08% 309
2019
Q2
Sell
-940
Closed -$250K 586
2019
Q1
$250K Buy
+940
New +$271K 0.05% 426
2017
Q4
Sell
-10,710
Closed -$2.61M 622
2017
Q3
$2.61M Buy
+10,710
New +$2.62M 0.62% 22

Other funds holding HUM

Bayesian Capital Management's HUM Position: Q4 2025 in Review

Bayesian Capital Management sold out of Humana (HUM) in Q4 2025, closing a stake of 2,256 shares — an estimated $587K sold.

Bayesian Capital Management first reported a position in HUM in Q3 2017 and held it in 12 quarters. The position peaked at $4.51M in Q3 2023. 863 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • Bayesian Capital Management reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 2,256 Humana shares in Q4 2025, an estimated $587K.
  • Bayesian Capital Management first reported a position in Humana in Q3 2017 and held it in 12 quarters.
  • Bayesian Capital Management's Humana position peaked at $4.51M in Q3 2023.
  • 863 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.